medical devices

Overview This report covers Parliamentary Questions (PQs) and Commission Answers published between 17.05.2026 and 24.05.2026. During this period, 22 new PQs were published and 4 Commission Answers became available. Key themes this week included zoonotic disease preparedness, food safety and agricultural imports, pharmaceutical regulation, and health financing. 🧬 Medicines & Regulation ❗ EMA’s evaluation of […]

Overview This report covers Parliamentary Questions (PQs) and Commission Answers published between Monday, 5 January 2026 and Sunday, 11 January 2026. During this period, 19 new PQs were published and 8 Commission Answers became available. Key themes this week included environmental health risks, particularly concerning PFAS and other chemical substances, water quality, and waste management. […]

This week in EU health policy: Debates on medicines regulation, public health risks like nitrous oxide, health system access, and environmental health links.

This week’s EU health policy: focus on workforce and access, regulation of medicines and data, AI governance, and environmental health and safety.

This week’s EU health policy developments range from cancer prevention and tobacco control to medical device reform, pesticide regulation, and healthcare workforce resilience. The Commission confirmed plans to revise the Medical Devices Regulation by end-2025, detailed actions on e-cigarettes and vector-borne diseases, and addressed chemical safety, cross-border health risks, and emergency access in an evolving digital and environmental landscape.

This week’s EU health and policy developments range from vaccine liability, disease preparedness, and women’s health to food additives, medical device reform, and healthcare funding. The Commission reaffirmed its commitments on vaccine safety, climate resilience, data protection, and equitable access to medicines and care across Member States.